Catalyst Pharmaceuticals Inc (CPRX)
Receivables turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 491,734 | 460,482 | 434,475 | 411,347 | 398,204 | 348,393 | 302,949 | 256,480 | 214,203 | 191,755 | 170,465 | 153,717 | 140,833 | 133,539 | 126,902 | 120,142 | 119,073 | 118,181 | 119,761 | 118,994 |
| Receivables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Receivables turnover = Revenue (ttm) ÷ Receivables
= $491,734K ÷ $—K
= —
The receivables turnover ratio for Catalyst Pharmaceuticals Inc remains unavailable for analysis as the data for receivables turnover for the periods up to December 31, 2024, is not provided. Receivables turnover is a key ratio that indicates how efficiently a company is managing its credit sales and collecting its accounts receivable. A higher turnover ratio typically reflects a shorter time span between credit sales and collection, which is usually favorable.
Without the specific values for receivables turnover, it is challenging to assess Catalyst Pharmaceuticals Inc's effectiveness in collecting its accounts receivable and managing credit sales during the given periods. Analyzing trends in receivables turnover over time can provide insights into the company's liquidity, financial health, and operational efficiency. If the data becomes available, a detailed analysis can be conducted to evaluate the company's performance in this aspect.
Peer comparison
Dec 31, 2024